MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: Highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidateKen‐ichi Yoshida, William J. Watkins, Ving J. Lee et al.|Bioorganic & Medicinal Chemistry|2007Cited by 130
MexAB-OprM-Specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: Discovery and early strategies for lead optimizationKiyoshi Nakayama, William J. Watkins, Jason Z. Zhang et al.|Bioorganic & Medicinal Chemistry Letters|2003Cited by 82
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore modelKiyoshi Nakayama, William J. Watkins, Jason Z. Zhang et al.|Bioorganic & Medicinal Chemistry Letters|2003Cited by 65